Blood Group Typing Market Size, Share, Outlook, Opportunities And Strategies 2024-2033

The blood group typing market size has grown rapidly in recent years. It will grow from $2.76 billion in 2023 to $3.15 billion in 2024 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to expansion in blood donation drives, aging population, rise in healthcare infrastructure development, rise in clinical trails.

The blood group typing market size is expected to see rapid growth in the next few years. It will grow to $5.18 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing demand for blood and blood-related products, rising prevalence of chronic diseases, rising road accidents, rise in healthcare spending. Major trends in the forecast period include automation and high-throughput systems, data integration, public health initiatives, technological innovations.

Market Overview -
Blood group typing is a method that tells the type of blood a person has, and it is done so that a person can safely donate blood or receive a blood transfusion.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=4092&type=smp

Fueling The Blood Group Typing Market The Impact Of Increasing Blood Donations And Transfusions
The increase in number of blood donations and transfusions drove the blood group typing market during the historic period. Different non-profit organizations, government organizations and other agencies are emphasizing the importance of blood donations and transfusions and spreading awareness through various campaigns. An increase in blood donations increased the demand for blood group typing so that the donor can know what type of blood they have. For instance, according to a report by the WHO in 2022, in high-income nations, which are home to 16% of the world's population, blood donations account for 40% of the 118.5 million donations that are made worldwide. Moreover, children under the age of five receive up to 54% of blood transfusions in low-income nations, compared to patients over 60 who receive up to 76% of transfusions in high-income countries. The increase in the number of blood donations and transfusions thereby contributed to the growth of the blood typing market.

Competitive Landscape -
Major companies operating in the blood group typing market market include Grifols S.A., Bio-Rad Laboratories Inc., Immucor Inc., Ortho-Clinical Diagnostics Inc., Quotient Limited, B. Braun Melsungen AG, AXO Science SAS, Agena Bioscience Inc., Merck KGaA, Beckman Coulter Inc., Sucuri Inc., Rapid Labs Ltd., Day Medical SA, Novacyt Group, Chemtrade Logistics Income Fund, DIAGAST SAS, Thermo Fisher Scientific Inc., One Lambda Inc., Tulip Diagnostics (P) Ltd., Guangzhou Wondfo Biotech Co. Ltd., Mesa Laboratories Inc., Hemaxis Inc., ZenTech S.A., Hemogenyx Pharmaceuticals plc, Lifespan Diagnostics LLC, TECOmedical AG, Blood Systems Inc., Japan Blood Products Organization, Medion Diagnostics GmbH, BioMedomics Inc., DiaSorin S.p.A., Grifols Diagnostic Solutions Inc., Hemo bioscience Inc.

Revolutionizing Blood Group Typing With Cutting-Edge Automated Technologies
Technological advancements such as automated technologies for blood typing gaining traction in the blood group typing market. Major companies in the market are focusing on introducing new types of tests based on innovative techniques that offer results in low turn-around time, with improved accuracy and efficiency. In September 2021, Ortho Clinical Diagnostics, a US-based in vitro diagnostics company, launched Immediate Spin Crossmatch (ISXM). ISXM is a serological test used in blood transfusions to identify ABO blood type mismatch between donor red blood cells and receiver serum or plasma. This new menu feature expands Ortho's complete automated testing offering with the addition of ISXM.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

Key Segments -

The blood group typing market market covered in this report is segmented -
1) By Test Type: Antibody Screening, Cross-Matching Tests, ABO Tests, Antigen Typing, HLA Typing
2) By Product: Instruments, Reagents And Kits
3) By Techniques: Serology Tests, Molecular Tests
4) By End User: Hospital Based Laboratories, Independent Laboratories And Blood Banks

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps"

This release was published on openPR.